e-learning
resources
Virtual 2021
05.09.2021
New insight into the immunology of allergies, asthma and COPD: from mouse to man
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Peculiarities of lipoperoxidation processes in chronic obstructive pulmonary disease associated with multiple myeloma
O. Smirnova (Krasnoyarsk, Russian Federation)
Source:
Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Session:
New insight into the immunology of allergies, asthma and COPD: from mouse to man
Session type:
E-poster
Number:
822
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Smirnova (Krasnoyarsk, Russian Federation). Peculiarities of lipoperoxidation processes in chronic obstructive pulmonary disease associated with multiple myeloma. 822
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Features of the chemiluminescent activity of neutrophils in chronic obstructive pulmonary disease associated with multiple myeloma
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020
Regulation disorders of pulmonary lipid metabolism in chronic obstructive pulmonary disease
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019
Erythropoietin dysregulation in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008
Oxidant metabolism in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 14S-27S
Year: 2003
Systemic inflammation in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 5S-13S
Year: 2003
Immunological profiling of chronic obstructive airways disease and idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
Rhinovirus-infection in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002
Pulmonary hypertension associated with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 656s
Year: 2006
Evaluation of oxidative stress on pathogenesis and severity of chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
Hormonal changes and catabolic/anabolic imbalance in chronic obstructive pulmonary disease and their importance for pulmonary cachexia
Source: Eur Respir J 2002; 20: Suppl. 38, 202s
Year: 2002
Cutaneous vascular spiders are associated with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Epidemiology of COPD and infectious lung diseases
Year: 2009
Peculiarities of cardiac rhythm in stable chronic obstructive pulmonary disease
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
Clinical-immunological efficiency of immunomodulation in chronic obstructive pulmonary deceases
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009
The role of inflamatory markers in obstructive pulmonary disease
Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care
Year: 2012
Role of oxidative-antioxidative imbalance and thyroid hormones in stable chronic obstructive pulmonary disease
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009
Anemia in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012
Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities
Year: 2012
Effects of severity of chronic obstructive pulmonary disease on thyroid function
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005
Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Pathophysiological features of chronic obstructive pulmonary disease in obese patients
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept